评估一种新型便携式自用设备「Beacon」测量临界闪烁频率作为肝性脑病检测方法
研究比较了153例慢性肝病患者使用新型便携设备Beacon与商用Lafayette闪烁融合系统测量临界闪烁频率的阈值。Beacon显示优异的重测信度(组内相关系数0.91-0.97)并与Lafayette-FFS值良好相关(组内相关系数0.77-0.84)。强制选择法CFF平均比极限法下降CFF高4.1 Hz。Beacon可由慢性肝病和肝硬化患者自行操作测量CFF,作为轻微型肝性脑病的经验证筛查测试。
要点
- Beacon测量CFF的重测信度为0.91-0.97,与Lafayette-FFS的组内相关系数为0.77-0.84。
- 强制选择法CFF平均比极限法下降CFF高4.1 Hz。
- Beacon可由慢性肝病和肝硬化患者自行操作,用于测量CFF以筛查轻微型肝性脑病。
核心结论
- Beacon可由慢性肝病和肝硬化患者自行操作测量CFF,CFF是经验证的轻微型肝性脑病筛查测试。
研究设计与样本
- 比较新型便携设备Beacon与商用Lafayette闪烁融合系统(Lafayette-FFS)测量CFF阈值的研究,纳入153例慢性肝病参与者,采用极限法和/或强制选择法进行CFF测试。
主要发现
- Beacon显示优异的重测信度,组内相关系数为0.91-0.97。
- Beacon与Lafayette-FFS值良好相关,组内相关系数为0.77-0.84。
- 强制选择法CFF平均比极限法下降CFF高4.1 Hz。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: We compared critical flicker frequency (CFF) thresholds obtained using a novel portable device "Beacon" with thresholds from the commercially available Lafayette Flicker Fusion System (Lafayette-FFS) in patients with cirrhosis. METHODS: One hundred fifty-three participants with chronic liver disease underwent CFF testing using Beacon and Lafayette-FFS with a method-of-limits and/or forced-choice protocol. RESULTS: Beacon demonstrated excellent test-retest reliability (intraclass correlation 0.91-0.97) and good correlation with the Lafayette-FFS values (intraclass correlation 0.77-0.84). Forced-choice CFF were on average 4.1 Hz higher than method-of-limits descending CFFs. DISCUSSION: Beacon can be self-administered by patients with chronic liver disease and cirrhosis to measure CFF, a validated screening test for minimal hepatic encephalopathy.
引用
- Vutien P, Li R, Karkar R, et al. Evaluating a Novel, Portable, Self-Administrable Device ("Beacon") That Measures Critical Flicker Frequency as a Test for Hepatic Encephalopathy. Am J Gastroenterol. 2023. PMID: 36746413. doi:10.14309/ajg.0000000000002211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。